Stay updated on Inhaled CMS in Bronchiectasis & P. Aeruginosa: Clinical Trial
Sign up to get notified when there's something new on the Inhaled CMS in Bronchiectasis & P. Aeruginosa: Clinical Trial page.

Latest updates to the Inhaled CMS in Bronchiectasis & P. Aeruginosa: Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov page now reflects a newer site revision, with the study record content unchanged.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page displays the ClinicalTrials.gov record for the completed Phase 3 PROMIS-I study of inhaled colistimethate sodium, including its study design, eligibility criteria, outcomes, locations, and study documents.SummaryDifference74%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check32 days agoChange DetectedA notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check46 days agoChange DetectedThe footer site revision changed from v3.7.0 to v3.7.1; the page continues to show a 403 error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content and navigation. This indicates the study details on this page are currently inaccessible.SummaryDifference16%

Stay in the know with updates to Inhaled CMS in Bronchiectasis & P. Aeruginosa: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled CMS in Bronchiectasis & P. Aeruginosa: Clinical Trial page.